Earnings Scheduled For March 11, 2022
Companies Reporting Before The Bell
• The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million.
87 Biggest Movers From Yesterday
Gainers
Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit.
Longeveron Sponsored Study Titled ‘Lomecel-B Effects on Alzheimer’s Disease (CLEARMIND)’ Posted To ClinicalTrials.gov; Study Is Recruiting
https://clinicaltrials.gov/ct2/show/NCT05233774
LGVN: Using Cellular Technology to Ease Major Medical Issues
By Brad Sorensen, CFA
NASDAQ:LGVN
READ THE FULL LGVN RESEARCH REPORT
53 Biggest Movers From Friday
Gainers
Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday.
Longeveron Highlights Publication Of Lomecel-B Phase 2b Trial Design In Journal Of Frailty And Aging
Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions,
UPDATE: Longeveron Says Expects To Publish Phase 1 Trial Results For Alzheimer’s Disease Trial In 2022; Expects To Rapidly Recruit, Enroll Phase 2a Trial
https://www.sec.gov/Archives/edgar/data/1721484/000121390022001252/ea153758ex99-1_longeveron.htm
Longeveron Issues Slides For Phase 2a Alzheimer’s Study
https://www.sec.gov/Archives/edgar/data/1721484/000121390022001252/ea153758ex99-1_longeveron.htm